Canada is the only nation with a broad public health system lacking universal coverage for pharmaceuticals. Despite fears that pharmacare would be too costly, it could end up saving Canadians money.
Articles on Prescription drugs
Displaying 81 - 100 of 110 articles
Amazon currently sells pretty much everything, including the kitchen sink, but medications are very different from books and fidget spinners.
The Orphan Drug Act was enacted 34 years ago to encourage the development of drugs for rare diseases. Drug companies were guaranteed seven years of exclusivity. Then the rush was on to run up prices.
Trump has vowed to use new bidding procedures to curb the soaring cost of new drugs. There’s a better solution, however, that doesn’t risk also curbing the development of lifesaving treatments.
The rising cost of drugs is more worrisome to most Americans than problems with Obamacare. Could proposals in California and Ohio help?
The issue of crime committed under the influence of prescription drugs has received high profile media attention. So should we be worried about a new wave of prescription drug-induced crime?
Doctors know that inappropriate prescribing can lead to antibiotic resistance. So why do they keep doing it?
How new medicines subsidised by individual nations in the EU is a complicated business.
When one in six hospitalisations of older patients are due to harm from their medicines, then something is going seriously wrong.
Pharmaceutical companies can use prescription medication ads to mislead an unwitting public for the sake of profits. While Australia prohibits such ads, the laws don’t go far enough.
The off-label use of medicines is not illegal and it doesn’t mean regulators have specifically “disapproved” its use. But there are a number of issues to consider before using a medicine off-label.
Biologics are widely accepted as the most effective way of treating certain diseases. They have become the fastest-growing class of therapeutic compounds, with about 300 now available for human use.
Australia’s drug regulator is looking into reclassifying codeine-based drugs as prescription-only. This is a good idea because the easy availability of these pinkillers is causing substantial harm.
When you think about substance use and teens, drugs like marijuana or Ecstasy might come to mind. But recreational prescription drug use is a significant problem. Nationally, 17.8% of high school students…
When retail health clinics move into new areas, antibiotic prescription rates go up.
More than eight out of every 10 prescriptions dispensed in the US is generic. This growth is due to a large number of top-selling drugs going off patent over the past decade, as well as innovations in…
One of the much-heralded platforms of the Abbott government is its promise to business to reduce red tape and burdensome regulatory obligations. Pharmaceuticals are a multi-billion dollar global industry…
In the 1930s, Harry J. Anslinger, the first head of the Federal Bureau of Narcotics, embarked on a fierce anti-marijuana campaign. Highlighted by the 1936 anti-marijuana film Reefer Madness – where marijuana…
Have you ever been advised to take a medicine with food? How about taking a medicine with cola or avoiding grapefruit? Hundreds of medicines have food-related dosing instructions. With four out of five…
“It might do me some good and it won’t hurt to give it a go.” How often have you heard a phrase like this? Most people have naïve optimism about medical care. That’s the finding of a systematic review…
Top contributors
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Associate Professor in Pharmacy Practice, Kingston University
-
Associate Professor in Pharmacy Practice, University of Bradford
-
Professor of Health Service Operations, School of Pharmacy & Medical Sciences, University of Bradford
-
University of Oxford
-
Professor of Health Law and Bioethics, Case Western Reserve University
-
Head of School and Dean of Pharmacy, University of Sydney
-
Associate Professor, Political Science, McMaster University
-
Associate Professor of Public Health, The Ohio State University
-
Doctoral Student in Biochemistry, University of Washington
-
Assistant Professor, Johns Hopkins University
-
Director of Health Policy, USC Schaeffer Center, and Associate Professor, University of Southern California
-
Senior research scholar and lecturer, Princeton Environmental Institute, Princeton University